Beta-catenin and cyclin D1 in mucoepidermoid carcinoma of variable histologic grades

Arch Otolaryngol Head Neck Surg. 2005 Aug;131(8):701-6. doi: 10.1001/archotol.131.8.701.

Abstract

Objective: To analyze the expression of beta-catenin and cyclin D1 in mucoepidermoid carcinoma (MEC) of variable histologic grades to establish a correlation between the expression of these proteins and the different histopathologic grades of this neoplasia.

Design: Immunohistochemical analysis of MEC.

Setting: Pathological Anatomy Service, Discipline of Oral Pathology, Department of Dentistry, Federal University of Rio Grande do Norte, Natal, Brazil.

Patients: Fifteen cases of MEC, graded and categorized according to criteria reported in the literature into 5 tumors with a low grade of malignancy, 4 with an intermediate grade, and 6 with a high grade.

Main outcome measures: Labeling patterns of beta-catenin and cyclin D1.

Results: No significant difference in beta-catenin labeling patterns was observed between low- and intermediate-grade tumors or between low- and high-grade tumors (P = .60 and P = .06, respectively; Fisher exact test), despite a strong tendency toward a difference in the latter. In contrast, a significant difference was noted between intermediate- and high-grade tumors (P = .03). For cyclin D1, no labeling was observed in any high-grade cases, and only 3 cases showed overexpression of this protein. Comparison of the labeling patterns among the different histologic grades revealed no significant difference.

Conclusions: The reduced expression of beta-catenin observed in all high-grade MECs is probably due to the loss of its adhesion function, which confers a greater invasive potential to these tumors. The overexpression of cyclin D1 observed in only 3 MEC cases suggests that this protein does not participate in the etiopathogenesis of these tumors, which implies that other genes are likely responsible.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Mucoepidermoid / metabolism
  • Carcinoma, Mucoepidermoid / pathology*
  • Child
  • Cyclin D1 / metabolism*
  • Cytoskeletal Proteins / metabolism*
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Male
  • Middle Aged
  • Staining and Labeling
  • Statistics, Nonparametric
  • Trans-Activators / metabolism*
  • beta Catenin

Substances

  • CTNNB1 protein, human
  • Cytoskeletal Proteins
  • Trans-Activators
  • beta Catenin
  • Cyclin D1